Cargando…

Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention

Androgens regulate biological pathways to promote proliferation, differentiation, and survival of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit this dependence and are used in advanced prostate cancer to control disease progression. Contemporary treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nouri, Mannan, Ratther, Ellca, Stylianou, Nataly, Nelson, Colleen C., Hollier, Brett G., Williams, Elizabeth D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274903/ https://www.ncbi.nlm.nih.gov/pubmed/25566507 http://dx.doi.org/10.3389/fonc.2014.00370

Ejemplares similares

A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome
por: Stylianou, Nataly, et al.
Publicado: (2018)

Correction: A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome
por: Stylianou, Nataly, et al.
Publicado: (2018)

Gene expression based inference of cancer drug sensitivity
por: Chawla, Smriti, et al.
Publicado: (2022)

hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen
por: Fraser, Jennifer A., et al.
Publicado: (2019)

Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2019)

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
por: Merkens, Lina, et al.
Publicado: (2022)

Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2019)

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2
por: Sarkar, Phoebe L., et al.
Publicado: (2019)

The senescence-associated secretory phenotype induces neuroendocrine transdifferentiation
por: Huna, Anda, et al.
Publicado: (2023)

The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells
por: Pernicová, Zuzana, et al.
Publicado: (2014)

Gremlin Activates the Smad Pathway Linked to Epithelial Mesenchymal Transdifferentiation in Cultured Tubular Epithelial Cells
por: Rodrigues-Diez, Raquel, et al.
Publicado: (2014)

Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
por: Sun, Nai-Yun, et al.
Publicado: (2020)

Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
por: Dong, Baijun, et al.
Publicado: (2020)

Targeting β-cell dedifferentiation and transdifferentiation: opportunities and challenges
por: Wang, Wenrui, et al.
Publicado: (2021)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors
Publicado: (1994)

Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline
por: Wang, Tung Yuan, et al.
Publicado: (2016)

Tbx18 Orchestrates Cytostructural Transdifferentiation of Cardiomyocytes to Pacemaker Cells by Recruiting the Epithelial–Mesenchymal Transition Program
por: Foster, D. Brian, et al.
Publicado: (2022)

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
por: Tse, B W C, et al.
Publicado: (2017)

Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model
por: Faugeroux, Vincent, et al.
Publicado: (2020)

miR‐200/375 control epithelial plasticity‐associated alternative splicing by repressing the RNA‐binding protein Quaking
por: Pillman, Katherine A, et al.
Publicado: (2018)

Characterization of corneal stromal stem cells with the potential for epithelial transdifferentiation
por: Hashmani, Khurram, et al.
Publicado: (2013)

Transdifferentiation of bovine epithelial cells towards adipocytes in the presence of myoepithelium
por: Sugathan, Subi, et al.
Publicado: (2020)

The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells
por: Dankert, Jaroslaw Thomas, et al.
Publicado: (2018)

Role of artesunate in TGF-β1-induced renal tubular epithelial-mesenchymal transdifferentiation in NRK-52E cells
por: Zhang, Yaqian, et al.
Publicado: (2017)

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2021)

Epithelial–mesenchymal plasticity in carcinoma metastasis
por: Tsai, Jeff H., et al.
Publicado: (2013)

Metabolic Plasticity and Epithelial-Mesenchymal Transition
por: Thomson, Timothy M., et al.
Publicado: (2019)

Is transdifferentiation in trouble?
por: Wells, William A.
Publicado: (2002)

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
por: Singh, Neha, et al.
Publicado: (2021)

Mesenchymal Stem Cells: Signaling Pathways in Transdifferentiation Into Retinal Progenitor Cells
por: Kadkhodaeian, Hamid Aboutaleb
Publicado: (2021)

Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
por: Zhang, Yun, et al.
Publicado: (2018)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014)

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
por: Su, Ruopeng, et al.
Publicado: (2022)

HDAC Inhibition Impedes Epithelial-Mesenchymal Plasticity and Suppresses Metastatic, Castration-Resistant Prostate Cancer
por: Ruscetti, Marcus, et al.
Publicado: (2015)

Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3
por: Li, Na, et al.
Publicado: (2018)

Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer
por: Wang, Guang-Chun, et al.
Publicado: (2021)

Loss of breast epithelial marker hCLCA2 promotes epithelial to mesenchymal transition and indicates higher risk of metastasis
por: Walia, Vijay, et al.
Publicado: (2011)

Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries
por: Corallino, Salvatore, et al.
Publicado: (2015)

Research models and mesenchymal/epithelial plasticity of osteosarcoma
por: Yu, Xiaobin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7ul69hhqod843oj82etj4g7ds